Form D · Biotechnology
KURA OPERATIONS, INC.
La Jolla, CA · CIK 0001631246
Offering snapshot reported Mar 19, 2015 · SEC filing
- Reported sold
- $60.4M Offering amount: $60.4M
- Investors reported
- 337 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 6, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 19, 2015 | Initial | $60,448,784 | No comparison | 337 | SEC filing |
| Jan 23, 2015 | Initial | $3,000,000 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $3.07M
- Form D file number
- 021-236277
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Leerink Partners LLC | 39011 | |
| National Securities Corporation | 7569 | |
| Livingston Securities LLC | 147364 |
Source: Form D, filed Mar 19, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Antonio Gualberto | Executive |
| Heidi Henson | Executive |
| Yi Liu | Executive |
| Annette North | Executive |
| Pingda Ren | Executive |
| Troy Wilson | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
11119 N Torrey Pines Rd Ste 125
La Jolla, CA, 92037
La Jolla, CA, 92037